von Willebrand factor: at the crossroads of bleeding and thrombosis

被引:54
作者
Denis, Cecile V. [1 ,2 ]
Lenting, Peter J. [1 ,2 ]
机构
[1] INSERM, U770, F-94276 Le Kremlin Bicetre, France
[2] Univ Paris Sud, UMR S 770, F-94276 Le Kremlin Bicetre, France
关键词
von Willebrand factor; Hemostasis; Thrombosis; von Willebrand disease; DISEASE TYPE 2B; VONWILLEBRAND-FACTOR MULTIMERS; CORONARY-HEART-DISEASE; DEEP-VEIN THROMBOSIS; FACTOR-VIII; PLATELET-ADHESION; DEFECTIVE BINDING; PLASMA-LEVELS; VENOUS THROMBOEMBOLISM; COLLAGEN-BINDING;
D O I
10.1007/s12185-012-1041-x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Hemostasis and thrombosis represent two sides of the same coin. Hemostasis maintains blood fluidity in the vascular system while allowing for rapid thrombus formation to prevent excessive hemorrhage after blood vessel injury. Thrombosis is a pathologic extension of the normal hemostatic mechanism, occurring when unwanted clot formation develops in certain pathological situations. The molecular mechanisms underlying both phenomena are fundamentally identical. One of the key players in both processes is the plasma glycoprotein von Willebrand factor, which perfectly illustrates this duality between hemostatic and thrombotic mechanisms. The purpose of this review is to discuss novel findings on the role of von Willebrand factor at this interface, and how some of these findings may help develop new therapeutic strategies.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 79 条
[1]
Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels [J].
Antoni, Guillemette ;
Oudot-Mellakh, Tiphaine ;
Dimitromanolakis, Apostolos ;
Germain, Marine ;
Cohen, William ;
Wells, Philip ;
Lathrop, Mark ;
Gagnon, France ;
Morange, Pierre-Emmanuel ;
Tregouet, David-Alexandre .
BMC MEDICAL GENETICS, 2011, 12
[2]
BANERJEE AK, 1990, BRIT J CLIN PRACT, V44, P326
[3]
Barr J, 2011, VONWILLEBRAND DIS BA, P49
[4]
Brill A., 2011, Journal of Thrombosis and Haemostasis
[5]
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models [J].
Brill, Alexander ;
Fuchs, Tobias A. ;
Chauhan, Anil K. ;
Yang, Janie J. ;
De Meyer, Simon F. ;
Koellnberger, Maria ;
Wakefield, Thomas W. ;
Laemmle, Bernhard ;
Massberg, Steffen ;
Wagner, Denisa D. .
BLOOD, 2011, 117 (04) :1400-1407
[6]
BUDDE U, 1993, BLOOD, V82, P1749
[7]
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease [J].
Casonato, A ;
Pontara, E ;
Sartorello, F ;
Cattini, MG ;
Sartori, MT ;
Padrini, R ;
Girolami, A .
BLOOD, 2002, 99 (01) :180-184
[8]
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance [J].
Castaman, Giancarlo ;
Tosetto, Alberto ;
Federici, Augusto B. ;
Rodeghiero, Francesco .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 (04) :647-654
[9]
von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins [J].
Chauhan, Anil K. ;
Kisucka, Janka ;
Lamb, Colin B. ;
Bergmeier, Wolfgang ;
Wagner, Denisa D. .
BLOOD, 2007, 109 (06) :2424-2429
[10]
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice [J].
Chen, Junmei ;
Reheman, Adili ;
Gushiken, Francisca C. ;
Nolasco, Leticia ;
Fu, Xiaoyun ;
Moake, Joel L. ;
Ni, Heyu ;
Lopez, Jose A. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02) :593-603